MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.clinre.2026.102940

Медицинская библиотека · Clinics and research in hepatology and gastroenterology · 2026

Prior Decompensation Shapes the Clinical Phenotype and the Prognostic Performance of Biochemical Liver-Failure Criteria in Hospitalised Cirrhosis patients: A Multicentre Study.

Roy Akash, Valsan Arun, Kumar Karan, Satwika Pasham, Nair Gowripriya, Venu Arathi, Iyengar Sowmya, Alla Manasa, Venishetty Shantan, Sharma Mithun, Saraswat Vivek, Goenka Mahesh, Padaki Nagaraj Rao, Reddy D Nageshwar, Kulkarni Anand V

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND AND AIMS: Index and recurrent decompensation have different impacts on the course of acute decompensation (AD). Contemporary biochemical liver failure definitions for acute-on-chronic liver failure (ACLF) do not distinguish between index and prior decompensation. We evaluated whether prior decompensation defines a clinically distinct phenotype and examined whether established biochemical liver failure criteria retain consistent prognostic performance across these phenotypes

METHODS

This multicentre study evaluated 966 adults hospitalized with AD across four centres in India, stratified into first-presentation (n = 364) and prior-decompensation (n = 602) cohorts. Biochemical thresholds from APASL (bilirubin ≥5 mg/dL and INR ≥1.5), CLEARED (≥7.5 mg/dL and INR≥1.5), and EASL-CLIF (bilirubin ≥12 mg/dL) were evaluated against 30-day mortality.

RESULTS

Patients with prior decompensation were older, more often had MASLD-related cirrhosis (21.3% vs 10.7%), and showed greater extra-hepatic organ failures. Thirty-day mortality was higher in patients with prior decompensation independent of MELD and baseline infection (40.5% vs 30.5%; adjusted RR 1.31, 95% CI 1.10-1.56, p=0.003), largely attributable to hepatic encephalopathy, which was twice as common (60% vs 29%). In the overall cohort, APASL and CLEARED modestly predicted mortality (OR 1.36 and 1.41, respectively), whereas EASL-CLIF threshold did not. In decompensation phenotype-stratified analysis, prognostic performance varied; biochemical thresholds were associated with 30-day mortality only among prior decompensation (APASL: OR 1.57; CLEARED: OR 1.67; CLIF-C: OR 1.71), but not in the first-presentation phenotype. The bilirubin-only CLIF-C OF liver-failure component captured the fewest deaths and showed significant phenotype-dependent prognostic behaviour.

CONCLUSION

Prior decompensation defines a clinically distinct, high-risk phenotype mediated by encephalopathy. Liver-failure criteria perform discordantly across phenotypes with different prognostic signals in first and prior decompensations.

Для цитирования: Roy Akash, Valsan Arun, Kumar Karan, Satwika Pasham, Nair Gowripriya, Venu Arathi, Iyengar Sowmya, Alla Manasa, Venishetty Shantan, Sharma Mithun, Saraswat Vivek, Goenka Mahesh, Padaki Nagaraj Rao, Reddy D Nageshwar, Kulkarni Anand V. Prior Decompensation Shapes the Clinical Phenotype and the Prognostic Performance of Biochemical Liver-Failure Criteria in Hospitalised Cirrhosis patients: A Multicentre Study.. Clinics and research in hepatology and gastroenterology. 2026. DOI: 10.1016/j.clinre.2026.102940.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.